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ABSTRACT 
 
 
 
 
 Molecular mechanics and dynamics calculations were used to simulate reactions 
of oxaliplatin and Pt(Me2dach)(oxalate) with methionine and guanine, where Me2dach is 
N,N-dimethyl-1,2-diaminocyclohexane.  The results were consistent with steric effects 
that resulted in chelation when Pt(Me2dach)(oxalate) reacted with N-acetylmethionine 
experimentally (Williams et al., 2013).  The energy difference due to ligand bulk that was 
predicted using molecular mechanics was also consistent with experimental results:  
oxaliplatin’s ligand bulk did not prevent the formation of bis products with 9-
ethylguanine and N-acetylmethionine, but the ligand bulk of Pt(Me2dach)(oxalate) did 
prevent bis product formation with N-acetylmethionine, resulting in chelation with the 
sulfur and oxygen atoms of the methionine residue (Williams et al., 2013).
  
Pt(Me2dach)(oxalate) did not prevent bis products with 9-ethylguanine (Williams et al., 
2013).
 
 
 
 
 
 
Keywords:  Molecular Mechanics, Oxaliplatin, Pt(Me2dach)(oxalate), Methionine, 
Guanine 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 Molecular mechanics is a form of software that models organic and inorganic 
compounds through parameters that determine the conformation and energy of a 
compound.  Molecular mechanics software utilizes force fields, which are sets of 
parameters used to calculate energy.  An AMBER (Assisted Model Building with Energy 
Refinement) force field was used in the molecular mechanics software because of its 
parameters for amino acids and DNA bases, molecules which were of focus.
1
  The 
AMBER force field has been modified several times from the force field developed by 
Weiner and his colleagues in the 1980’s.2  How parameters are obtained varies from each 
modification, but in general, these force fields rely heavily upon ab initio calculations of 
simple molecules, X-rays of crystal structures, IR (Infrared spectroscopy), and NMR 
(Nuclear Magnetic Resonance spectroscopy) spectra to obtain the data necessary to create 
parameters for factors such as bond lengths, bond angles, and electrostatic interactions.
2-4
   
  This software was used to model oxaliplatin, a platinum-containing anticancer 
compound used in the treatment of colorectal cancer (Figure 1.1).
5-7
  It was developed 
and utilized because it is not cross-resistant with its predecessors, cisplatin and 
carboplatin.
8
  Oxaliplatin and other platinum-containing anticancer compounds function 
by having their leaving groups (the portion of the compound that is removed by another 
molecule, for example, oxalate for oxaliplatin) replaced with two water molecules inside 
2 
 
a cell.  Upon reaching the nucleus, the water molecules are replaced by DNA bases as 
platinum binds to DNA.  It is the binding to DNA that can result in replication errors that 
lead to apoptosis.  Though platinum is thermodynamically favored to bind to DNA bases 
over amino acids, platinum is kinetically favored to bind to amino acids.
9,10
  It is 
therefore relevant in anticancer research to determine what extent of bulk will shift 
platinum’s kinetic preference to DNA bases. 
 
 
 
In addition to oxaliplatin, molecular mechanics was also used to model 
Pt(Me2dach)(oxalate), a derivative of oxaliplatin (Figure 1.2).  The difference between 
these two compounds is due to their carrier ligands (Figure 1.1).  Oxaliplatin contains the 
dach (diaminocyclohexane) carrier ligand, while Pt(Me2dach)(ox) contains the Me2dach 
(1,2-dimethyl diaminocyclohexane) carrier ligand.  Both compounds contain the oxalate 
leaving group.  Me2dach differs from dach in that both of its chiral nitrogen atoms have a 
single bond with a methyl group, creating a larger bulk than dach.  Since amino acids are 
larger than DNA bases, our goal was to see if the bulk difference between oxaliplatin and 
Pt(Me2dach)(ox) created a difference in reactivity between these two compounds with 
guanine and methionine.  
Figure 1.1: Oxaliplatin 
The carrier ligand is the top portion of 
this molecule, including Pt.  The leaving 
ligand is everything below in this two-
dimensional representation. 
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Figure 1.2:  Pt(Me2dach)(oxalate) 
Contains the oxalate leaving ligand like oxaliplatin, 
but the carrier ligand contains two methyl groups that 
replace two of the hydrogens in oxaliplatin’s dach 
carrier ligand. 
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CHAPTER 2 
 
 
EXPERIMENT 
 
 
 Molecular mechanics data were obtained using HyperChem 7 (Hypercube, Inc.) 
on a Dell Optiplex GX260 computer with Windows XP.  An AMBER89 force field was 
used with modifications to contain parameters developed in past research for platinum 
atoms bound to guanine and methionine.
3,11
  To analyze the bulk difference between 
Pt(Me2dach)(oxalate) and oxaliplatin, molecular mechanics was used to construct models 
with varying conformations, including various chiralities of the amine nitrogens, carbons 
1 and 2 of the cyclohexane chair of the carrier ligand, and the sulfur of the methionine 
residue.  Once structures were made, energy minimizations were done on the models.  
Molecular dynamics calculations were then done on the models analogously with 
previous research: models were simulated at 300 Kelvin for 250 picoseconds, with a 
conformation saved at each picosecond and the lowest total energy of each conformation 
was recorded.
9
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CHAPTER 3 
 
RESULTS 
 
 
Oxaliplatin with bis-methionine:  [Pt(dach)(N-AcMet-S)2]  
 To distinguish rotamers, the first two chiralities are those of the carbons of the 
cyclohexane ring bound to the amine nitrogens.  The next two chiralities are those of the 
two sulfur atoms of the two methionine residues.  Head-to-head (HH), tails-to-tails (TT), 
head-to-tails (HT), or tails-to-head (TH) refer to the positioning of the methyl group 
attached to each methionine’s sulfur atom.  If it is bound in such a way that it points 
above the platinum plane, it is in the heads (H) configuration, and below the platinum 
plane is tails (T).  The methyl groups’ orientations are listed in order from the methionine 
residue on the left first. 
 
Figure 3.1:  RR-RR-HH, the lowest 
total energy conformation for 
oxaliplatin with bis-methionine, with 
the methionine residues oriented 
closest to viewer.  The methyl groups 
attached to the sulfur atom of each 
methionine residue are pointing above 
the platinum plane, while the rest of 
each residue is positioned below the 
platinum plane. 
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 In the graph below (table 3.1), it is shown that RR-RR-HH (Figure 3.1) was the 
conformation that provided the lowest total energy.  The reason why it was the lowest 
total energy conformation can in part be explained by running single point calculations, 
which show electrostatic interactions, hydrogen bond strain, and total bond strain.  
Compared to the relatively highest total energy structures, the relatively lower total 
energy structures had lower total bond strain and lower electrostatic interactions and 
hydrogen bond strain. 
 
 
Rotamer Lowest Total Energy (kcal/mol) Time (ps) 
RR-RR-HH -11.4834 85 
RR-RR-TT -6.49225 59 
RR-RR-HT -10.7318 91 
RR-SS-HH 9.671332 2 
RR-SS-TT 11.00478 158 
RR-SS-HT 16.87738 1 
RR-SR-HH 9.457934 10 
RR-SR-TT -10.4101 21 
RR-SR-HT 19.58132 151 
RR-SR-TH -1.19333 32 
 
 
Table 3.1 
 
 
 
Oxaliplatin with bis-guanine:  [Pt(dach)(9-EtG)2] 
 To distinguish rotamers, the first two chiralities listed are those of the two 
cyclohexane ring carbons bound to the amine nitrogens.  Since each guanine residue 
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contains no chiral atoms, the direction and placement of the hydrogen bonded to the C8 
carbons (the carbons double-bonded to the N7 nitrogens bound to platinum) were used to 
label conformations as HH (head-to-head), and lambda HT and delta HT.
12
  Lambda HT 
refers to the C8 hydrogen bond pointing below and above the platinum plane from the 
left and right guanine residues, respectively.
12
  Delta HT (Figure 3.2) refers to the C8 
hydrogen pointing above and below the platinum plane from the left and right guanine 
residues, respectively.
12 
 
Rotamer Lowest Total Energy (kcal/mol) Time (ps) 
RR-HH -16.7662 242 
RR-Lambda HT -16.097 142 
RR-Delta HT -16.998 164 
 
 
Table 3.2 
 
 
 
Figure 3.2:  RR-Delta HT 
From the left to right direction, the 
carbon-hydrogen bond of the carbon 
double-bonded to the nitrogen in each 
guanine residue points above and 
below the platinum plane. 
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Pt(Me2dach) with bis-methionine:  [Pt(Me2dach)(N-AcMet-S)2] 
Rotamers were distinguished by the chiralities of the amine nitrogens and 
cyclohexane ring carbons (ex. SRRS), and the chiralities of the sulfur atoms and the 
orientation of the methyl groups bound to the sulfurs were distinguished by the same 
method as the oxaliplatin with bis-methionine rotamers.  
 The energy differences seen in the structures below are mostly due to total bond 
strain; SRRS-SR-HT (Figure 3.3, the lowest total energy structure) had a relatively low 
total bond strain (~21 kcal/mole) compared to SRRS-SS-HT (Figure 3.4, the highest total 
energy structure), which had a total bond strain of ~38 kcal/mol.  The bond strain 
difference is illustrated by how the square planar geometry of the four bonds to platinum 
is distorted to a larger degree in SRRS-SS-HT (Figure 3.4).  
 
 
 
 
 
 
 
 
 
 
 
Figures 3.3 & 3.4:  SRRS-SR-
HT(above) and SRRS-SS-HT (below).  
Note that in SRRS-SS-HT, the 
platinum plane is to a larger degree 
distorted from an ideal square planar 
geometry due to bond strain. 
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Rotamer Lowest Total Energy (kcal/mol) Time (ps) 
SRRS-RR-HH 6.95555 242 
SRRS-RR-TT 9.414564 249 
SRRS-RR-HT 15.15593 115 
SRRS-SR-HH 9.524042 159 
SRRS-SR-TT 18.42109 49 
SRRS-SR-HT 5.4734 73 
SRRS-SR-TH 12.08102 21 
SRRS-SS-HH 7.578558 177 
SRRS-SS-TT 6.665445 218 
SRRS-SS-HT 21.69378 68 
 
Table 3.3 
 
 
 
Pt(Me2dach) with bis-guanine:  [Pt(Me2dach)(9-EtG)2] 
 Rotamers were distinguished like those of dach with bis-guanine, except the 
amine nitrogens’ chiralities are included.  The three conformations had similar 
electrostatic interactions and hydrogen bond strains combined at about -23 kilocalories 
per mole.  SRRS-HH and SRRS-Delta HT had higher total bond strains because their 
cyclohexane rings were out of the stable “chair” conformation. 
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Rotamer Lowest Total Energy (kcal/mol) Time (ps) 
SRRS-HH -5.50239 102 
SRRS-Lambda HT -11.7471 249 
SRRS- Delta HT -6.87903 126 
 
 
Table 3.4 
 
 
 
SRRS S,O-Chelates:  [(S,R,R,S)-Pt(Me2dach)(N-AcMet-S,O)]
+ 
 Chelates within the SRRS and RSSR chirality were separated by the chirality of 
the sulfur atom and whether the carbonyl oxygen (OXT) pointed above or below the 
platinum plane (up or down) and then whether it pointed toward or away from the 
platinum atom (in or out).  Electrostatic interactions, hydrogen bond strain, and total bond 
strain differences were seen by comparing relatively low total energy structures to 
relatively high total energy structures.  In high energy structures, the total bond strain 
makes the cyclohexane chair out of plane with the square planar geometry of the four 
platinum bonds (Figure 3.5). 
 
Figure 3.5: SRRS-R-COOH-up and 
out 
The bond strain is high enough that the 
cyclohexane chair on the left side of 
the molecule is nearly perpendicular to 
the platinum plane though it should lie 
within the plane. 
11 
 
 
Rotamer 
Lowest Total Energy 
(kcal/mol) 
Time (ps) 
R-COOH up and in 22.19559 32 & 58 
R-COOH up and out 33.47956 129 
R-COOH down and in 21.1443 250 
R-COOH down and out 13.86348 197 
S-COOH up and in 14.2397 129 
S-COOH up and out 31.66563 39 
S-COOH down and in 19.78293 55 
S-COOH down and out 16.3332 186 & 232 
 
Table 3.5  
 
RSSR S,O-Chelates:  [(R,S,S,R)-Pt(Me2dach)(N-AcMet-S,O)]
+
 
 A similar relationship to the SRRS chelates was seen in that the low total energy 
structures had both lower electrostatic interactions, hydrogen bond strain, and total bond 
strain than the high total energy structures.  The structures with the relatively lowest total 
energies were the ones that had their cyclohexane chairs more in line with the platinum 
plane. 
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Rotamer 
Lowest Total Energy 
(kcal/mol) 
Time (ps) 
R-COOH up and in 19.23563 130 
R-COOH up and out 36.70739 218 
R-COOH down and in 17.73952 219 
R-COOH down and out 21.28113 60 
S-COOH up and in 19.00508 152 
S-COOH up and out 33.68429 64 
S-COOH down and in 21.64079 48 
S-COOH down and out 28.57723 175 
 
 
Table 3.6 
 
 
 
In summary, all of the lowest total energy structures are listed: 
 
 
 
Rotamer Lowest Total Energy (kcal/mol) Time (ps) 
 
[Pt(dach)(N-AcMet-S)2] 
RR-RR-HH 
 
-11.4834 85 
 
[Pt(dach)(9-EtG)2] 
RR-Delta HT 
 
-16.998 164 
 
[Pt(Me2dach)(N-AcMet-S)2] 
SRRS-SR-HT 
 
5.4734 73 
 
[Pt(Me2dach)(9-EtG)2] 
SRRS-Lambda HT 
 
-11.7471 249 
 
[Pt(Me2dach)(N-AcMet-S,O)]
+
 
R-COOH down and out 
 
13.86348 197 
 
[Pt(Me2dach)(N-AcMet-S,O)]
+ 
R-COOH down and in 
 
17.73952 219 
 
 
Table 3.7 
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CHAPTER 4 
 
 
DISCUSSION 
 
 
 The lowest total energy conformation of oxaliplatin with bis-methionine was 
about 6 kilocalories per mole higher than the lowest total energy conformation of 
oxaliplatin with bis-guanine.  With Pt(Me2dach) with bis-methionine, the lowest total 
energy conformation was about 17 kilocalories per mole greater than the lowest total 
energy conformation with bis-guanine.  This 11 kilocalories per mole difference between 
oxaliplatin and Pt(Me2dach)(ox) is the result of the bulk difference between dach and 
Me2dach being used as carrier ligands.  This is comparable to past research with the 
Me4en ligand (N,N,N
’
,N
’
-tetramethylethylenediamine) in that bis products with 
methionine “would have severe interligand clashes,” while this effect would be lessened 
with bis-guanine products.
11
 
 NMR data revealed that the reaction of Pt(Me2dach)(ox) with N-acetylmethionine 
resulted in chelation with the sulfur and oxygen atoms of a single methionine residue.
1
  
Oxaliplatin could form bis products with methionine at high concentrations of N-
acetylmethionine; at low concentrations a sulfur-nitrogen chelate could form.
1
  Both 
Pt(Me2dach)(oxalate) and oxaliplatin could form bis products with 9-ethylguanine.
1
  This 
is consistent with molecular mechanics and dynamics calculations in that the lowest total 
energy structures of Pt(Me2dach)(oxalate) and oxaliplatin with bis products with guanine 
 14 
 
had comparably low total energy values.  These values, as well as the energy of the 
lowest total energy structure of oxaliplatin with bis-methionine, are significantly lower 
than the energy of the lowest total energy conformation of Pt(Me2dach)(oxalate) with bis-
methionine (table 3.7), showing the thermodynamic disparity. 
 It was originally determined that the sulfur-oxygen chelates formed by the 
reaction of Pt(Me2dach)(oxalate) with N-acetylmethionine were of SRRS (N,C,C,N) 
chirality.
1
  It was later shown that when Pt(Me2dach)(oxalate) reacted with N-
acetylmethionine, chelates were also made of RSSR chirality.  Of the SRRS and RSSR 
chelates, NMR and other spectra data were unable to determine any further the 
conformations of the chelates, including the chiralities of the sulfur atoms.  Molecular 
mechanics and dynamics data showed three conformations of the SRRS chelates having 
relatively low energies compared to the other conformations.  The data predicts that the 
SRRS chelates made have two conformations with the sulfur atoms in the S chirality and 
one conformation with the sulfur atom in the R chirality.  Of the RSSR chelates, both 
spectra data and molecular mechanics data were insufficient to determine the 
conformation of the RSSR chelates formed.  Molecular mechanics and dynamics data 
were unable to provide a prediction of the conformation because there were multiple 
conformations of relatively low energy.  
In regard to practical applications, the formation of sulfur-oxygen chelates by the 
reaction of Pt(Me2dach)(ox) and N-acetylmethionine does not shift reactivity with 
platinum in guanine’s favor because the chelate product is stable enough that it cannot be 
knocked off by even a more thermodynamically favored reactant.
1
  Therefore, the ability 
of Pt(Me2dach)(ox) to bind to DNA is limited by the formation of a product with an 
 15 
 
amino acid that could possibly be stable for years.  It is also significant that 
Pt(Me2dach)(ox) and oxaliplatin reacted with N-acetylmethionine at equal rates, showing 
that the extra bulk of the Me2dach ligand did not prevent the bonding of N-
acetylmethionine before chelation.
1
  Therefore, it can be concluded that the bulk 
difference between oxaliplatin and Pt(Me2dach)(ox) does not create a difference in 
reactivity between methionine and guanine, thus not giving an advantage to either of 
these compounds in this aspect of anticancer activity. 
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